Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VIMSELTINIB vs VINCRISTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VIMSELTINIB vs VINCRISTINE: Safety Overview

Metric VIMSELTINIB VINCRISTINE
Total FAERS Reports 170 72,554
Deaths Reported 0 14,548
Death Rate N/A 20.1%
Hospitalizations 5 26,911
Average Patient Age 45.6 yrs 41.6 yrs
% Female Patients 55.4% 43.7%
FDA Approval Date Feb 14, 2025 Approved Prior to Jan 1, 1982
Manufacturer Deciphera Pharmaceuticals, LLC Hospira, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued